Department of Ophthalmology, University of Gothenburg, Sweden.
Acta Ophthalmol. 2011 Mar;89(2):116-23. doi: 10.1111/j.1755-3768.2009.01653.x.
This study aimed to analyse the decline in visual acuity (VA) during normal ageing in two Scandinavian population samples of subjects aged ≥ 70 years and to study the age-specific decline in VA in eyes with early age-related maculopathy (ARM).
We carried out a cross-sectional analysis of data pertaining to VA in the better eye in one population sample from Oulu (OU), Finland (aged 70-82 years) and a second population sample from Gothenburg (GG), Sweden (aged 82 or 88 years). The change in VA with age was evaluated in healthy eyes (OU, n = 119; GG, n = 40) and in eyes with early ARM (OU-ARM, n = 22; GG-ARM, n = 114) using linear regression or logistic regression. The results were compared with those of previous reports.
Our population samples showed a significant decrease with age in VA in healthy eyes in subjects aged ≥ 44 years using both statistical models. Comparisons with previous reports demonstrated a homogeneity in the decline in VA with age. On average, 0.3 logMAR are lost from middle age up to 88 years, presumably as a result of physiological ageing. In early ARM, the rate of age-specific decline in VA more than doubled and the prevalence of VA < 0.5 markedly increased.
Visual acuity in healthy eyes declines with age from middle age onwards. The decrease in VA possibly accelerates in subjects aged > 70 years, although no significant evidence for this was found. An age-specific decline in VA is shown in eyes with early ARM. These results are important for the evaluation of age-specific treatment results.
本研究旨在分析两个斯堪的纳维亚人群样本中≥70 岁人群的视力(VA)下降情况,并研究早期年龄相关性黄斑病变(ARM)眼中 VA 的年龄特异性下降。
我们对芬兰奥卢(OU)人群样本(年龄 70-82 岁)和瑞典哥德堡(GG)人群样本(82 或 88 岁)中较好眼的 VA 数据进行了横断面分析。使用线性回归或逻辑回归评估健康眼(OU,n=119;GG,n=40)和早期 ARM 眼(OU-ARM,n=22;GG-ARM,n=114)中 VA 随年龄的变化。结果与以往报道进行了比较。
我们的人群样本显示,在≥44 岁的健康眼中,两种统计学模型均显示 VA 随年龄显著下降。与以往报道的比较表明,VA 随年龄的下降具有同质性。平均而言,从中年到 88 岁,0.3 个 logMAR 丧失,可能是生理衰老的结果。在早期 ARM 中,VA 年龄特异性下降的速度增加了一倍以上,VA<0.5 的患病率明显增加。
健康眼的 VA 从中年开始随年龄下降。VA 的下降速度在>70 岁的人群中可能会加快,尽管没有发现明显的证据。早期 ARM 中存在 VA 的年龄特异性下降。这些结果对于评估特定年龄的治疗结果非常重要。